Why this role matters

Opportunities like this are rare, even in rare disease. At Jubilant, you will not just support a brand or optimize a lifecycle. You will help bring a life-changing radiopharmaceutical treatment to children facing one of the most challenging diseases, neuroblastoma. This is not about incremental improvements to an established therapy. It is about shaping how a breakthrough treatment reaches patients by building access pathways, support systems, and commercialization strategy. For a marketing leader who wants to move beyond traditional brand work and directly impact treatment access, patient experience, and outcomes, this is a career-defining chance.

The Opportunity

We are seeking an experienced rare disease or oncology marketing leader to build and lead the end-to-end go-to-market strategy for a high-impact radiopharmaceutical therapy. This role owns strategy across pre-launch, launch, and post-launch, with a strong focus on treatment...